Breast cancer is the second leading cause of death for women worldwide. The
heterogeneity of this disease presents a big challenge in its therapeutic management …

Breast cancer is the most prevalent cancer in the world. Currently, the main treatments for
breast cancer are radiotherapy, chemotherapy, targeted therapy and surgery. The treatment …

Breast cancer (BC) is a multifaceted disease characterized by distinct molecular subtypes
and varying responses to treatment. In BC, the phosphatidylinositol 3-kinase (PI3K) pathway …

Introduction The resistance to chemotherapy is a significant hurdle in breast cancer
treatment, prompting the exploration of innovative strategies. This review discusses the …

Background Breast cancer (BC) is known as the most common cancer in women.
Discovering novel and effective drugs is a priority for the treatment of BC. Oxypalmatine …

Breast cancer is a global health concern, with increasing disease burden and disparities in
access to healthcare. Late diagnosis and limited treatment options in underserved areas …

Doxorubicin (DOX) is a cornerstone chemotherapeutic agent for the treatment of several
malignancies such as breast cancer; however, its activity is ameliorated by the development …

Breast cancer is a major cause of death worldwide. The complexity of endocrine regulation
in breast cancer may allow the cancer cells to escape from a particular treatment and result …

Background Breast cancer (BC) is a complex disease with various subtypes and genetic
alterations that impact DNA repair pathways. Understanding these pathways is essential for …

Breast cancer is the most frequently diagnosed malignancy and the leading cause of cancer-
related death in women worldwide. Breast cancer development and progression are mainly …